Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$27,000.00

Leveraging Murine Models to Uncover SETD2's Essentiality in Neurulation

EF 2024-25

Résumé
Neural tube defects (NTDs) are severe congenital malformations affecting 1 in 1000 pregnancies globally, making them one of the most common birth defects. These defects include spina bifida and anencephaly which can lead to severe disabilities or be fatal. Recent advancements have identified many genes involved in NTDs, particularly those encoding chromatin-modifying enzymes like SETD2, which deposits H3K36me3, a crucial marker for chromatin readers such as DNMT3B. SETD2 is essential for embryo and brain development, with Setd2 knockout mice failing to complete neural tube closure by embryonic day 10.5 (E10.5). However, the exact epigenetic mechanisms and affected cell types remain unclear. To study SETD2's role in neural tube formation, I will track marker proteins (Pax6, Pax7, Shh, Sox2) in Setd2+/+, Setd2+/-, and Setd2-/- mice at stages E6.5, E8.5, and E10.5 via histology, and conduct spatial transcriptome analysis to track markers at the transcript level as well. I hypothesize a gradient of Shh downregulation correlating with Setd2 deficiency. I will also profile dysregulated cell types with ChIP-seq and RNA-Seq. Interestingly, DNMT3B localizes to the anterior neural tube, and its loss is embryonic lethal at E11.5, similar to Setd2 lethality at E10.5. To test this potential mechanistic explanation for NTD, ChIP-seq will confirm H3K36me3 reduction, while whole genome bisulfite sequencing will assess whether DNA methylation patterns match H3K36me3 loss in the anterior neural tube of Setd2-deficient mice. Understanding the spatio-temporal dysregulation of cell types due to Setd2 deficiency may lead to genetic tests to predict the risk of NTDs, allowing for better family planning and early interventions.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
529895
Name
Liu James I
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Leveraging Murine Models to Uncover SETD2's Essentiality in Neurulation
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Brain Development; Chromatin Modification; Dna Methylation; Epigenetics; Histology; Neural Tube Closure; Neural Tube Defects; Neurulation; Sequencing; Setd2
Abstract
Neural tube defects (NTDs) are severe congenital malformations affecting 1 in 1000 pregnancies globally, making them one of the most common birth defects. These defects include spina bifida and anencephaly which can lead to severe disabilities or be fatal. Recent advancements have identified many genes involved in NTDs, particularly those encoding chromatin-modifying enzymes like SETD2, which deposits H3K36me3, a crucial marker for chromatin readers such as DNMT3B. SETD2 is essential for embryo and brain development, with Setd2 knockout mice failing to complete neural tube closure by embryonic day 10.5 (E10.5). However, the exact epigenetic mechanisms and affected cell types remain unclear. To study SETD2's role in neural tube formation, I will track marker proteins (Pax6, Pax7, Shh, Sox2) in Setd2+/+, Setd2+/-, and Setd2-/- mice at stages E6.5, E8.5, and E10.5 via histology, and conduct spatial transcriptome analysis to track markers at the transcript level as well. I hypothesize a gradient of Shh downregulation correlating with Setd2 deficiency. I will also profile dysregulated cell types with ChIP-seq and RNA-Seq. Interestingly, DNMT3B localizes to the anterior neural tube, and its loss is embryonic lethal at E11.5, similar to Setd2 lethality at E10.5. To test this potential mechanistic explanation for NTD, ChIP-seq will confirm H3K36me3 reduction, while whole genome bisulfite sequencing will assess whether DNA methylation patterns match H3K36me3 loss in the anterior neural tube of Setd2-deficient mice. Understanding the spatio-temporal dysregulation of cell types due to Setd2 deficiency may lead to genetic tests to predict the risk of NTDs, allowing for better family planning and early interventions.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Liu, James I
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~